{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:53:25Z","timestamp":1791273205029,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100028612","name":"Kaiser Permanente Division of Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lungcan.2026.109539","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:03:29Z","timestamp":1783983809000},"page":"109539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasms"],"prefix":"10.1016","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2619-5945","authenticated-orcid":false,"given":"Daniela","family":"Scattolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4108-3969","authenticated-orcid":false,"given":"Frank W.J.","family":"Heijboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2397-9852","authenticated-orcid":false,"given":"Giulia","family":"Pigato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules L.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst-Jan M.","family":"Speel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijmen","family":"van Weert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5578-7902","authenticated-orcid":false,"given":"Daphne W.","family":"Dumoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biancamaria Di","family":"Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8808-4952","authenticated-orcid":false,"given":"Lisa M.","family":"Hillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6105-182X","authenticated-orcid":false,"given":"Anne-Marie C.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pasello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"von der Th\u00fcsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2026.109539_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102768","article-title":"The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: focus on small cell lung cancer","author":"Scattolin","year":"2024","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109539_b0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.15252\/embr.201540964","article-title":"SLFN 11 inhibits checkpoint maintenance and homologous recombination repair","volume":"17","author":"Mu","year":"2016","journal-title":"EMBO Rep."},{"issue":"18","key":"10.1016\/j.lungcan.2026.109539_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13184601","article-title":"Precision oncology with drugs targeting the replication stress, ATR, and schlafen 11","volume":"13","author":"Jo","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109539_b0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.molcel.2018.01.012","article-title":"SLFN11 blocks stressed replication forks independently of ATR","volume":"69","author":"Murai","year":"2018","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.lungcan.2026.109539_b0025","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/s41416-021-01560-1","article-title":"Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response","volume":"125","author":"Willis","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109539_b0030","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.18632\/oncotarget.6413","article-title":"Epigenetic inactivation of the putative DNA\/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs","volume":"7","author":"Nogales","year":"2016","journal-title":"Oncotarget"},{"issue":"7391","key":"10.1016\/j.lungcan.2026.109539_b0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"issue":"37","key":"10.1016\/j.lungcan.2026.109539_b0040","doi-asserted-by":"crossref","first-page":"15030","DOI":"10.1073\/pnas.1205943109","article-title":"Putative DNA\/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents","volume":"109","author":"Zoppoli","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lungcan.2026.109539_b0045","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-16-1040","article-title":"PARP inhibitor activity correlates with SLFN11 expression and demonstrates synergy with temozolomide in small cell lung cancer","author":"Lok","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109539_b0050","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.21037\/tlcr-21-437","article-title":"SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer","volume":"10","author":"Kundu","year":"2021","journal-title":"Transl Lung Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109539_b0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.dnarep.2015.01.011","article-title":"Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activity","volume":"28","author":"Sousa","year":"2015","journal-title":"DNA Repair (Amst)"},{"issue":"47","key":"10.1016\/j.lungcan.2026.109539_b0060","doi-asserted-by":"crossref","first-page":"76534","DOI":"10.18632\/oncotarget.12266","article-title":"Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition","volume":"7","author":"Murai","year":"2016","journal-title":"Oncotarget"},{"issue":"October","key":"10.1016\/j.lungcan.2026.109539_b0065","first-page":"1","article-title":"Identification of Schlafen-11 as a target of CD47 signaling that regulates sensitivity to ionizing radiation and topoisomerase inhibitors","volume":"9","author":"Kaur","year":"2019","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109539_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0224267","article-title":"Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy","volume":"14","author":"Shee","year":"2019","journal-title":"PLoS One"},{"issue":"532","key":"10.1016\/j.lungcan.2026.109539_b0075","first-page":"1","article-title":"BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers","volume":"12","author":"Coussy","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.lungcan.2026.109539_b0080","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.MCT-19-0926","article-title":"SLFN11 expression in advanced prostate cancer and response to platinum-based chemotherapy","author":"Conteduca","year":"2020","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109539_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-020-07574-x","article-title":"The first evidence for SLFN11 expression as an independent prognostic factor for patients with esophageal cancer after chemoradiotherapy","volume":"20","author":"Kagami","year":"2020","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109539_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13061296","article-title":"Candidate markers of olaparib response from genomic data analyses of human cancer cell lines","volume":"13","author":"Amuzu","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.lungcan.2026.109539_b0095","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/j.gastro.2023.02.005","article-title":"Disruption of SLFN11 deficiency\u2013induced CCL2 signaling and macrophage M2 polarization potentiates anti\u2013PD-1 therapy efficacy in hepatocellular carcinoma","volume":"164","author":"Zhou","year":"2023","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.lungcan.2026.109539_b0100","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1158\/1535-7163.MCT-18-0028","article-title":"Novel fluoroindenoisoquinoline non-camptothecin topoisomerase I inhibitors","volume":"17","author":"Marzi","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"15","key":"10.1016\/j.lungcan.2026.109539_b0105","first-page":"OF1","article-title":"SLFN11 is a BRCA independent biomarker for the response to platinum-based chemotherapy in high-grade serous ovarian cancer and clear cell ovarian carcinoma","author":"Akashi","year":"2023","journal-title":"Mol. Cancer Ther."},{"issue":"18","key":"10.1016\/j.lungcan.2026.109539_b0110","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109539_b0115","first-page":"39","article-title":"Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids","author":"Caplin","year":"2015","journal-title":"Ann ofOncology."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109539_b0120","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2606","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2026.109539_b0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMoa2502099","article-title":"Tarlatamab in small-cell lung cancer after platinum-based chemotherapy","author":"Mountzios","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2026.109539_b0130","doi-asserted-by":"crossref","unstructured":"N. Alcala, N L, AAG G. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids. (2019). doi:10.1038\/s41467-019-11276-9.","DOI":"10.1038\/s41467-019-11276-9"},{"key":"10.1016\/j.lungcan.2026.109539_b0135","first-page":"4339","article-title":"Integrative genomic characterization identifies molecular subtypes of lung carcinoids","author":"Laddha","year":"2019","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109539_b0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jtho.2024.11.018","article-title":"Identification of defined molecular subgroups on the basis of immunohistochemical analyses and potential therapeutic vulnerabilities of pulmonary carcinoids","volume":"20","author":"Leunissen","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109539_b0145","doi-asserted-by":"crossref","unstructured":"C. Rudin, E. Brambilla, C. Faivre-Finn, J. Sage, Small-cell lung cancer. Nat. Rev. Dis. Prim., doi:10.1038\/s41572-020-00235-0.","DOI":"10.1038\/s41572-020-00235-0"},{"key":"10.1016\/j.lungcan.2026.109539_b0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03099-x","article-title":"Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors","author":"George","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2026.109539_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2025.104234","article-title":"Comprehensive analysis of neurogenic differentiation factor 1 (NEUROD1), achaete-scute homolog 1 (ASCL1), POU class 2 homeobox 3 (POU2F3), and yes-associated protein 1 (YAP1) expression signatures reveals unique large-cell neuroendocrine carcinoma (LCNEC)","volume":"105","author":"Heijboer","year":"2025","journal-title":"Lab Investig."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109539_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100677","article-title":"OTP, CD44, and Ki-67: a prognostic marker panel for relapse-free survival in patients with surgically resected pulmonary carcinoid","volume":"38","author":"Moonen","year":"2025","journal-title":"Mod. Pathol."},{"issue":"November","key":"10.1016\/j.lungcan.2026.109539_b0165","article-title":"Treatment outcomes in patients with stage IV large cell neuroendocrine carcinoma: a nationwide registry study","volume":"210","author":"Heijboer","year":"2025","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.lungcan.2026.109539_b0170","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008974","article-title":"Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironment","volume":"12","author":"Tosi","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"April","key":"10.1016\/j.lungcan.2026.109539_b0175","article-title":"Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung","author":"Hanley","year":"2018","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.lungcan.2026.109539_b0180","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-24-0286","article-title":"Chromothripsis-mediated small cell lung carcinoma","author":"Rekhtman","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.lungcan.2026.109539_b0185","first-page":"1","article-title":"Frequent mutations in chromatin-remodelling genes genes in pulmonary carcinoids","author":"Fernandez-cuesta","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lungcan.2026.109539_b0190","doi-asserted-by":"crossref","unstructured":"S. Peripolli, L. Meneguello, C. Perrod, et al., Oncogenic c-Myc induces replication stress by increasing cohesins chromatin occupancy in a CTCF-dependent manner. 2024. doi:10.1038\/s41467-024-45955-z.","DOI":"10.1038\/s41467-024-45955-z"},{"issue":"17","key":"10.1016\/j.lungcan.2026.109539_b0195","doi-asserted-by":"crossref","first-page":"28575","DOI":"10.18632\/oncotarget.15338","article-title":"Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer","volume":"8","author":"Stewart","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109539_b0200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jtho.2021.08.763","article-title":"Molecular subtypes of primary SCLC tumors and their associations with neuroendocrine and therapeutic markers","volume":"17","author":"Qu","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109539_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108296","article-title":"SCLC-CellMiner: a resource for small cell lung cancer cell line genomics and pharmacology based on genomic signatures","volume":"33","author":"Tlemsani","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.lungcan.2026.109539_b0210","article-title":"Outcomes of advanced pulmonary large cell neuroendocrine carcinoma stratified by RB1 loss, SLFN11 expression, and tumor mutational burden","author":"Sabari","year":"2018","journal-title":"ASCO Annu Meet."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109539_b0215","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00428-020-02840-6","article-title":"Immunohistochemical analysis of SLFN11 expression uncovers potential non-responders to DNA-damaging agents overlooked by tissue RNA-seq","volume":"478","author":"Takashima","year":"2021","journal-title":"Virchows Arch."},{"key":"10.1016\/j.lungcan.2026.109539_b0220","doi-asserted-by":"crossref","unstructured":"H. Asamura, T. Kameya, Y. Matsuno, et al., Neuroendocrine neoplasms of the lung: a prognostic spectrum. J. Clin. Oncol., 24(1) (2006), doi:10.1200\/JCO.2005.04.1202.","DOI":"10.1200\/JCO.2005.04.1202"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:26:56Z","timestamp":1791271616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"alternative-id":["S0169500226006008"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109539","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasms","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109539"}}